← Leaderboards
Laura-Isobel McCall
University Of Oklahoma
$3,552,176
Attributed
$5,011,426
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,011,426 · 5
By mechanism
R01$4,126,682 · 3
R21$884,744 · 2
Top collaborators
- Robert Henry Cichewicz5 shared
- Zhibo Yang4 shared
- Natalie Mccarter Bowman2 shared
- Robert H Gilman2 shared
Most similar at University Of Oklahoma
Same institution · by research overlap
- Robert Henry Cichewicz$10,878,573
- Zhibo Yang$2,101,051
Others in their field
Other Emerging Leaders on “Drug Development”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$256,285,510
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Klaus Romero · Critical Path Institute$88,602,036
Research focus
Drug DevelopmentBenznidazoleParasitesInfectionPharmaceutical PreparationsAntiparasitic AgentsTrypanosoma CruziMetabolomicsAffectEnsureMortalitySuccessTissuesPersonsPublic HealthCostAcylcarnitineAmericanClinicHeart DiseasesChagas DiseaseHeart DamageChronicHeart Failure
Grant awards (18)
Deciphering the mechanism of action of carnitine, a novel treatment for chronic Chagas disease$528,585
R01 · FY2025 · AI · contact PI
Novel single-cell mass spectrometry methods to assess the role of intracellular drug concentration and metabolism in antimicrobial treatment failure$420,914
R01 · FY2025 · AI · contact PI
An LCMS-guided bioanalytical approach for rational natural product library design and optimization$259,912
R01 · FY2025 · GM · contact PI
Deciphering the mechanism of action of carnitine, a novel treatment for chronic Chagas disease$466,493
R01 · FY2024 · AI · contact PI
Novel single-cell mass spectrometry methods to assess the role of intracellular drug concentration and metabolism in antimicrobial treatment failure$348,186
R01 · FY2024 · AI · contact PI
An LCMS-guided bioanalytical approach for rational natural product library design and optimization$265,497
R01 · FY2024 · GM · contact PI
Novel single-cell mass spectrometry methods to assess the role of intracellular drug concentration and metabolism in antimicrobial treatment failure$377,968
R01 · FY2023 · AI · contact PI
Deciphering the mechanism of action of carnitine, a novel treatment for chronic Chagas disease$291,099
R01 · FY2023 · AI · contact PI
An LCMS-guided bioanalytical approach for rational natural product library design and optimization$205,280
R01 · FY2023 · GM · contact PI
Deciphering the mechanism of action of carnitine, a novel treatment for chronic Chagas disease$130,557
R01 · FY2023 · AI · contact PI
An LCMS-guided bioanalytical approach for rational natural product library design and optimization$70,554
R01 · FY2023 · GM · contact PI
Novel single-cell mass spectrometry methods to assess the role of intracellular drug concentration and metabolism in antimicrobial treatment failure$1
R01 · FY2023 · AI · contact PI
Deciphering the mechanism of action of carnitine, a novel treatment for chronic Chagas disease$402,774
R01 · FY2022 · AI · contact PI
An LCMS-guided bioanalytical approach for rational natural product library design and optimization$358,862
R01 · FY2022 · GM · contact PI
Small molecule biomarkers of cardiac Chagas disease progression$234,971
R21 · FY2022 · AI · contact PI
Oral carnitine administration as a novel treatment for chronic-stage Chagas disease$232,500
R21 · FY2021 · AI · contact PI
Small molecule biomarkers of cardiac Chagas disease progression$223,523
R21 · FY2021 · AI · contact PI
Oral carnitine administration as a novel treatment for chronic-stage Chagas disease$193,750
R21 · FY2020 · AI · contact PI